Sign In
|
Register
|
About Walnut Creek Guide
|
Contact Us
Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast
|
Traffic
Walnut Creek Guide News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Walnut Creek Guide Gas Prices
Ski And Snow Reports
Financial Markets
American
Bakery
Brew Pubs
Coffee Houses
Eating Places
Fast Food
German
Greek
Hawaiian
Italian
Jewish
Latin American
Lebanese
Mediterranean
Pizza
Seafood
Soul Food
Sports Bars
Steaks, Chops
Thai
Wine
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Attractions
Museums
Nightlife
Family Activities
Arts & Culture
Annual Events
Accommodations
Hotel and Motel Management
Hotels & Resorts
Vacation Rentals
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Museums
Theatres
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Senior Citizen Services
Attractions & Entertainment
Air Tours
Amusement & Water Parks
Galleries
General Attractions
Jeep & Hummer Tours
Movie Theatres
Museums
Parks & Preserves
Theatre
Tours
ATV & Hummer Tours
Automotive
Auto Detail
Auto Rental
Car Washes
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Motorcycles
Parking & Storage
Parts & Supplies
Repair & Service
Beauty & Fitness
Barbers
Beauty Salons
Dance Clubs & Studios
Fitness Programs
Health Clubs & Gyms
Massage
Weight Loss
Business & Professional Services
Appraisers
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Cemeteries & Funeral Services
Communications Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Data Processing Service
Durable Goods
Employment Services, Placement & Agencies
Energy Services
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Equipment Rentals
Graphic Design & Art
Human Resource Services
Industrial
Internet Services
Management Services
Marketing & Advertising Services
Media Services
Office Furniture, Equipment & Supplies
Office Machines & Service
Office Supplies
Payroll Services
Photography
Printing & Publishing
Public Relations & Publicity
Research
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Telecommunications
Trucking & Hauling
Video Production
Waste Management & Recycling
Wholesale
Commercial Contractors
Concierge & Lifestyle Services
Contractors
Air Conditioning
Architects
Building Contractors & Consultants
Carpentry
Concrete
Drywall, Plastering & Insulation
Electric
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Inspectors & Surveyors
Landscaping
Painting & Wallcovering
Plumbing
Pools, Spas & Saunas
Special Trade Contractors
Domestic Services
Child Care Services
Housecleaning
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Misc. Financial Services
Mortgage Lenders
Personal
Golf
Government
City & County Government
Federal Government
National Government
Post Offices
State Government
Health and Medicine
Alternative Medicine / Acupuncture
Animal Health
Chiropractors
Counseling
Dentistry
Drug Stores & Pharmacies
Emergency Services
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Medical Equipment & Supplies
Mental Health
Nutrition
Physical Therapist
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Building Materials & Hardware
Cabinets, Racks & Shelves
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Doors, Windows & Drapery
Electric
Floor Coverings
Furniture
Glass
Heating, Cooling & AC
Home Improvement Centers
Kitchen
Lamps & Lighting
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Pest Control
Plumbing
Pools, Spas & Saunas
Safety & Security
Tree Services
Water Supply
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Audio & Visual
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Health Care & Pharmaceutical
Industrial Supplies & Services
Machine Shops
Metal
Textiles & Apparel
Media
Cable & Pay TV Services
Print Publications
Television Stations
Meeting & Event Planning
Audio & Visual
Event Facilities
Exhibit Designers
Lodging
Meeting Planners
Party Rentals & Entertainment
Travel Arrangement & Services
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Personal Service
Barbers, Beauty Salons & Spas
Car Wash
Dry Cleaning and Laundry
Shoe Repair
Pets
Pet Shops
Pet Supplies & Food - Retail
Training
Veterinary Hospitals
Real Estate
Appraisers
Assisted Living & Elder Care Service
Commercial
Condominiums
Developers
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Religion
Relocation
Movers
Storage
Restaurants
Bakery
Brew Pubs
Coffee Houses
Eating Places
Fast Food
Italian
Mexican
Pizza
Seafood
Sports Bars
Steaks, Chops
Wine
Shopping
Accessories
Antiques
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Department Stores
Discount Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Gourmet & Specialty Foods
Grocery Stores
Health Food Stores
Hobbies & Crafts
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Notions
Office Supplies & Service
Pharmacies
Rental Service Stores
Repair Shops
Resale Shops
Shoe Stores
Shopping Centers & Malls
Smoke Shops
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Sports & Recreation
Arenas and Venues
Associations & Clubs
Bicycles
Boating
Camping & Parks
Dance Clubs & Studios, Instruction
Fishing, Fishing Charters and Tours
Golf Courses
Golf Equipment & Supplies
Health Clubs
Instruction
Professional Sports Teams
Recreation Facilities
Sporting Goods
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Airlines & Airports
Auto Rentals
Bus Lines & Charters
Hotels & Resorts
RV Parks and Recreational Vehicles
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Ceremony & Reception Venues
Entertainment
Florists
Health & Beauty
Photographers & Videographers
Transportation
Apartments
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Walnut Creek Guide
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Morphosys Ag ADR
(NQ:
MOR
)
18.39
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Morphosys Ag ADR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in Its Clinical Practice Guidelines in Oncology for B-cell Lymphomas
March 15, 2022
BOSTON, MA / ACCESSWIRE / March 15, 2022 / MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE:MOR)(NASDAQ:MOR), announced today that the National Comprehensive Cancer Network(R) (NCCN)...
From
MorphoSys AG
Via
AccessWire
Earnings Outlook For MorphoSys
March 15, 2022
MorphoSys (NASDAQ:MOR) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Invitation to MorphoSys' Full Year Results 2021 Conference Call on March 17, 2022
March 10, 2022
Conference Call Alert PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 10, 2022 / MorphoSys AG (FSE:MOR);(NASDAQ:MOR) will publish its results for the financial year 2021 on March 16, 2022 at 9:00 pm...
From
MorphoSys AG
Via
AccessWire
MorphoSys Discontinues US Discovery Activities, Takes €231M Impairment Charge
March 10, 2022
MorphoSys AG (NASDAQ: MOR) has reported a non-cash impairment charge of €231 million on goodwill after consolidating research and discovery functions. This...
Via
Benzinga
MorphoSys AG Reports Non-Cash Impairment Charge of € 231 Million on Goodwill After Consolidation of Research and Discovery Functions; Corresponding Increase of Group Operating Expenses in 2021
March 10, 2022
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 10, 2022 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR)...
From
MorphoSys AG
Via
AccessWire
MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report
January 24, 2022
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 24, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) was acknowledged as a Best Practice Leader in the European Women on Boards' Gender Equality Index Report,...
From
MorphoSys AG
Via
AccessWire
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
January 18, 2022
- Preliminary 2021 Monjuvi U.S. net product sales of US$ 79.1 million ( € 66.9 million) - Anticipated 2022 Monjuvi U.S. net product sales in the range of US$ 110 to 135 million PLANEGG / MUNICH,...
From
MorphoSys AG
Via
AccessWire
MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
January 10, 2022
PLANEGG / MUNICH, GERMANY / ACCESSWIRE / Janauary 10, 2022 / MorphoSys AG (FSE:MOR; NASDAQ:MOR), announced today that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 40...
From
MorphoSys AG
Via
AccessWire
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022
January 14, 2022
Upgrades According to Seaport Global, the prior rating for Lennar Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 06, 2022
Gainers Freeline Therapeutics (NASDAQ:FRLN) stock increased by 58.1% to $3.1 during Thursday's pre-market session. The company's market cap stands at $111.0...
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
December 22, 2021
Gainers BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical,...
Via
Benzinga
MorphoSys Presents Latest Data from the Phase 2 MANIFEST Study Evaluating the Potential of Pelabresib in the Treatment of Myelofibrosis
December 12, 2021
MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis - Data presented during poster and oral sessions at the 63rd...
From
MorphoSys AG
Via
AccessWire
MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
December 11, 2021
- RE-MIND2 compared patient outcomes from pivotal L-MIND study with matched patient populations treated with NCCN/ESMO recommended therapies - Results from the retrospective cohort analysis indicate...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Product Safety
MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi®) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
December 11, 2021
From
Incyte
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
Gainers Reshape Lifesciences (NASDAQ:RSLS...
Via
Benzinga
Corporate Calendar 2022
November 29, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 29, 2021 / Corporate Calendar 2022 Dear Madam/Sir, Please note MorphoSys' financial reporting dates 2022 as follows: Publication of Interim Statement /...
From
MorphoSys AG
Via
AccessWire
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 22, 2021
Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (...
Via
Benzinga
MorphoSys AG (MOR) Q3 2021 Earnings Call Transcript
November 11, 2021
MOR earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 11, 2021
Gainers ADMA Biologics (NASDAQ:ADMA) shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
November 11, 2021
- Monjuvi U.S. net product sales of US$ 22.0 million (€ 18.6 million), 22% growth Q-Q - Ten abstracts, including two oral presentations, accepted at upcoming ASH - Pelabresib data for arm 3 of MANIFEST...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
MorphoSys Announces Departure of Roland Wandeler
November 09, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 9, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that Roland Wandeler, Ph.D., has decided to step down from his position as Chief Operating...
From
MorphoSys AG
Via
AccessWire
Exposures
Product Safety
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
MorphoSys Presents Early Felzartamab Data From Autoimmune Kidney Disease Trial
November 05, 2021
MorphoSys AG (NASDAQ: MOR) presented interim results from the M-PLACE Phase 1b/2a study with felzartamab at the 2021 Annual Meeting of the American Society of...
Via
Benzinga
MorphoSys Presents Interim Results from M-PLACE Study with Felzartamab during American Society of Nephrology Annual Meeting
November 04, 2021
Felzartamab has the potential to rapidly and substantially reduce anti-PLA2R antibody titers in patients with anti-PLA2R-positive membranous nephropathy PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November...
From
MorphoSys AG
Via
AccessWire
MorphoSys to Present MANIFEST and RE-MIND2 Data from Expanded Hematology-Oncology Portfolio at the 2021 American Society of Hematology (ASH) Annual Meeting
November 04, 2021
- Updates from MANIFEST phase 2 trial in patients with myelofibrosis, including clinical updates on JAK naïve patients treated with pelabresib in combination with ruxolitinib, including translational...
From
MorphoSys AG
Via
AccessWire
MorphoSys AG Announces Monjuvi(R) Sales for the First Nine Months and Third Quarter of 2021 and Invitation to the Upcoming Conference Call on November 11, 2021
November 02, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 2, 2021 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) today announces that revenues from product sales of Monjuvi (R) (tafasitamab-cxix) in the U.S. amount to €...
From
MorphoSys AG
Via
AccessWire
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.